Cargando…

Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington’s Disease

Several cannabinoids afforded neuroprotection in experimental models of Huntington’s disease (HD). We investigated whether a 1:1 combination of botanical extracts enriched in either ∆(9)-tetrahydrocannabinol (∆(9)-THC) or cannabidiol (CBD), which are the main constituents of the cannabis-based medic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valdeolivas, Sara, Sagredo, Onintza, Delgado, Mercedes, Pozo, Miguel A., Fernández-Ruiz, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412270/ https://www.ncbi.nlm.nih.gov/pubmed/28333097 http://dx.doi.org/10.3390/ijms18040684

Ejemplares similares

Pharmacokinetics of Sativex(®) in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders
por: Fernández-Trapero, María, et al.
Publicado: (2020)

Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome
por: Rubio, Marta, et al.
Publicado: (2016)

Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!
por: Russo, Margherita, et al.
Publicado: (2015)

Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
por: Russo, Margherita, et al.
Publicado: (2015)

The Oxidation of Phytocannabinoids to Cannabinoquinoids
por: Caprioglio, Diego, et al.
Publicado: (2020)

Antibacterial Effects of Phytocannabinoids
por: Scott, Cassidy, et al.
Publicado: (2022)

Phytocannabinoids in the Pharmacotherapy of Psoriasis
por: Wroński, Adam, et al.
Publicado: (2023)

Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases
por: Franco, Graziella dos Reis Rosa, et al.
Publicado: (2021)

Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree
por: Corrêa, Bernardo Barahona, et al.
Publicado: (2006)

Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
por: D’hooghe, Marie, et al.
Publicado: (2021)

Review of the neurological benefits of phytocannabinoids
por: Maroon, Joseph, et al.
Publicado: (2018)

The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis: Rationale, study design, and methodology
por: Russo, Margherita, et al.
Publicado: (2017)

Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
por: Cifelli, Pierangelo, et al.
Publicado: (2020)

Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics
por: Nahler, Gerhard
Publicado: (2022)

Phytocannabinoids, the Endocannabinoid System and Male Reproduction
por: Lim, Jinhwan, et al.
Publicado: (2023)

Editorial: Cannabinoids as potential treatment for neurological diseases
por: Gómez-Cañas, María, et al.
Publicado: (2022)

Biosynthesis of Phytocannabinoids and Structural Insights: A Review
por: Govindarajan, Rasiravathanahalli Kaveriyappan, et al.
Publicado: (2023)

Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?
por: Nigro, Ersilia, et al.
Publicado: (2021)

Absence of Acanthocytosis in Huntington’s Disease-like 2: A Prospective Comparison with Huntington’s Disease
por: Anderson, David G., et al.
Publicado: (2017)

Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments
por: Satta, Valentina, et al.
Publicado: (2021)

Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
por: Berk, Klaudia, et al.
Publicado: (2021)

How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases
por: Dziemitko, Sylwia, et al.
Publicado: (2023)

The Biochemistry of Phytocannabinoids and Metabolic Engineering of Their Production in Heterologous Systems
por: Blatt-Janmaat, Kaitlyn, et al.
Publicado: (2021)

Phytocannabinoids Biosynthesis in Angiosperms, Fungi, and Liverworts and Their Versatile Role
por: Arif, Yamshi, et al.
Publicado: (2021)

An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models
por: Straiker, Alex, et al.
Publicado: (2021)

Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes
por: Di Meo, Camilla, et al.
Publicado: (2022)

Phytocannabinoids: Chromatographic Screening of Cannabinoids and Loading into Lipid Nanoparticles
por: Zielińska, Aleksandra, et al.
Publicado: (2023)

Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection
por: de Brito Siqueira, Ana L.G., et al.
Publicado: (2023)

Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis
por: Hilliard, A., et al.
Publicado: (2012)

Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
por: Sönmez, Aynur, et al.
Publicado: (2021)

Respiratory decline is integral to disease progression in Huntington's disease
por: Jones, Una, et al.
Publicado: (2016)

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)
por: Messina, Silvia, et al.
Publicado: (2017)

Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice
por: Paes-Colli, Yolanda, et al.
Publicado: (2022)

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy
por: Senn, Lara, et al.
Publicado: (2020)

A systematic review of minor phytocannabinoids with promising neuroprotective potential
por: Stone, Nicole L., et al.
Publicado: (2020)

Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
por: Bielawiec, Patrycja, et al.
Publicado: (2020)

Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances
por: Farrelly, Aaron M., et al.
Publicado: (2021)

The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels
por: Udoh, Michael, et al.
Publicado: (2022)

Epicutaneous Sensitization to the Phytocannabinoid β-Caryophyllene Induces Pruritic Inflammation
por: Inan, Saadet, et al.
Publicado: (2023)

Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach
por: Wright, Stephen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qo2g2u755f3c5sakk8140bsfdc